ChemicalBook > CAS DataBase List > Tomuzotuximab
Tomuzotuximab
- Product Name
- Tomuzotuximab
- CAS No.
- 1646321-00-7
- Chemical Name
- Tomuzotuximab
- Synonyms
- Tomuzotuximab;Research Grade Tomuzotuximab;Research Grade Tomuzotuximab(DHB86905)
- CBNumber
- CB38081037
- Formula Weight
- 0
- MOL File
- Mol file
More
Less
Tomuzotuximab Chemical Properties,Usage,Production
Uses
Tomuzotuximab (Anti-Human EGFR Recombinant Antibody) is a fully human glycoengineered IgG1 monoclonal antibody against EGFR. Tomuzotuximab has anticancer effects[1].
References
[1] Waer Fiedler, et al. Phase I study of tomuzotuximab, a glycoengineered therapeutic antibody against the epidermal growth factor receptor, in patients with advanced carcinomas. ESMO Open. 2018 Feb 1;3(2):e000303. DOI:10.1136/esmoopen-2017-000303
Tomuzotuximab Preparation Products And Raw materials
Raw materials
Preparation Products
More
Less
Tomuzotuximab Suppliers
- Tel
- 177-54423994 17754423994
- Fax
- QQ:2853530913
- 2853530910@QQ.com
- Country
- China
- ProdList
- 8000
- Advantage
- 62
- Tel
- 15817493340
- 981810490@qq.com
- Country
- China
- ProdList
- 1566
- Advantage
- 58
- Tel
- 027-65317797 15926423062
- Fax
- QQ:422450190
- 422450190@qq.com
- Country
- China
- ProdList
- 10308
- Advantage
- 58
- Tel
- 027-65279366 18108604356
- products@biolabreagent.com
- Country
- China
- ProdList
- 9868
- Advantage
- 58
- Tel
- 13720134139 086-15871494362 13720134139
- orders@jknbiochem.com
- Country
- China
- ProdList
- 6762
- Advantage
- 58
- Tel
- 021-65675885 18964387627
- customer_service@efebio.com
- Country
- China
- ProdList
- 11973
- Advantage
- 58
- Tel
- 0731-13823398 15111215862
- 313359644@qq.com
- Country
- China
- ProdList
- 4161
- Advantage
- 58
- Tel
- 17316404525 17316404525
- 209533805@qq.com
- Country
- China
- ProdList
- 9763
- Advantage
- 58
- Tel
- 0573-83568680 18057391398
- 3956524501@qq.com
- Country
- China
- ProdList
- 1442
- Advantage
- 58
- Tel
- 027-87008169 17762441161
- info@atagenix.com
- Country
- China
- ProdList
- 10001
- Advantage
- 58
1646321-00-7, TomuzotuximabRelated Search:
Lumiliximab
Stamulumab
Certolizumab
Namilumab
Bavituximab
Fremanezumab
Rovalpituzumab
Tisotumab
Efungumab
Parsatuzumab